Skip to content
June 30, 2026
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Kanker Payudara

Kanker Payudara

Primary Menu
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Watch
The Life and Legacy of Dr. Juliet Daniel: A Pioneer in Cancer Research and Champion of Health Equity the-life-and-legacy-of-dr-juliet-daniel-a-pioneer-in-cancer-research-and-champion-of-health-equity
  • Patient Advocacy and Support

The Life and Legacy of Dr. Juliet Daniel: A Pioneer in Cancer Research and Champion of Health Equity

Ammar Sabilarrohman September 11, 2025 0
The scientific community, McMaster University, and the global network of cancer researchers are mourning the profound loss...
Read More Read more about The Life and Legacy of Dr. Juliet Daniel: A Pioneer in Cancer Research and Champion of Health Equity
A Historic Milestone: Australia Eliminates Trachoma as a Public Health Problem a-historic-milestone-australia-eliminates-trachoma-as-a-public-health-problem
  • Breast Cancer Prevention and Lifestyle

A Historic Milestone: Australia Eliminates Trachoma as a Public Health Problem

Muslim September 10, 2025 0
In a monumental achievement for global health, the World Health Organization (WHO) has officially validated Australia for...
Read More Read more about A Historic Milestone: Australia Eliminates Trachoma as a Public Health Problem
Strategic Expansion: Angelini Pharma to Acquire Catalyst Pharmaceuticals in $4.1 Billion Neuroscience Powerplay strategic-expansion-angelini-pharma-to-acquire-catalyst-pharmaceuticals-in-4-1-billion-neuroscience-powerplay
  • Treatment Innovations

Strategic Expansion: Angelini Pharma to Acquire Catalyst Pharmaceuticals in $4.1 Billion Neuroscience Powerplay

Nila Kartika Wati September 9, 2025 0
By Gwendolyn Wu Published May 7, 2026 In a move that signals a significant shift in the...
Read More Read more about Strategic Expansion: Angelini Pharma to Acquire Catalyst Pharmaceuticals in $4.1 Billion Neuroscience Powerplay
From Pandemic Giant to Oncology Pioneer: BioNTech’s High-Stakes Strategic Pivot from-pandemic-giant-to-oncology-pioneer-biontechs-high-stakes-strategic-pivot
  • Chemotherapy and Targeted Therapy

From Pandemic Giant to Oncology Pioneer: BioNTech’s High-Stakes Strategic Pivot

Nana Wu August 22, 2025 0
Introduction The biotechnology landscape is defined by cycles of explosive growth and sobering consolidation, yet few trajectories...
Read More Read more about From Pandemic Giant to Oncology Pioneer: BioNTech’s High-Stakes Strategic Pivot
A New Era of Equity: Canada Establishes First-Ever National Standards for Breast Cancer Care a-new-era-of-equity-canada-establishes-first-ever-national-standards-for-breast-cancer-care
  • Global Breast Cancer Awareness

A New Era of Equity: Canada Establishes First-Ever National Standards for Breast Cancer Care

Nila Kartika Wati August 15, 2025 0
In a landmark shift for the Canadian healthcare landscape, the nation’s preeminent breast cancer experts have officially...
Read More Read more about A New Era of Equity: Canada Establishes First-Ever National Standards for Breast Cancer Care
Unraveling the Colorectal Cancer Paradox: A Breakthrough in Immunotherapy Research unraveling-the-colorectal-cancer-paradox-a-breakthrough-in-immunotherapy-research
  • Medical Research and Clinical Trials

Unraveling the Colorectal Cancer Paradox: A Breakthrough in Immunotherapy Research

Raul Delapena Setiawan August 14, 2025 0
NEW YORK, NY – For decades, the intricate dance between the immune system and cancer has presented...
Read More Read more about Unraveling the Colorectal Cancer Paradox: A Breakthrough in Immunotherapy Research
Moderna’s mRNA Flu Vaccine Shows Superior Efficacy, Navigates FDA Review After Initial Hesitation modernas-mrna-flu-vaccine-shows-superior-efficacy-navigates-fda-review-after-initial-hesitation
  • Medical Research and Clinical Trials

Moderna’s mRNA Flu Vaccine Shows Superior Efficacy, Navigates FDA Review After Initial Hesitation

Ammar Sabilarrohman August 13, 2025 0
A groundbreaking Phase III trial has demonstrated that Moderna’s experimental mRNA-based flu vaccine, mRNA-1010, significantly outperforms a...
Read More Read more about Moderna’s mRNA Flu Vaccine Shows Superior Efficacy, Navigates FDA Review After Initial Hesitation
Japan Faces Uphill Battle to Achieve Lung Cancer Screening Goals Amidst Persistent Regional and Gender Disparities japan-faces-uphill-battle-to-achieve-lung-cancer-screening-goals-amidst-persistent-regional-and-gender-disparities
  • Medical Research and Clinical Trials

Japan Faces Uphill Battle to Achieve Lung Cancer Screening Goals Amidst Persistent Regional and Gender Disparities

Raul Delapena Setiawan August 13, 2025 0
Tokyo, Japan – May 7, 2026 – Japan’s ambitious national target of achieving 60% lung cancer screening...
Read More Read more about Japan Faces Uphill Battle to Achieve Lung Cancer Screening Goals Amidst Persistent Regional and Gender Disparities
From Patient to Healer: A Survivor’s Inspiring Journey to Becoming a Nurse from-patient-to-healer-a-survivors-inspiring-journey-to-becoming-a-nurse
  • Patient Advocacy and Support

From Patient to Healer: A Survivor’s Inspiring Journey to Becoming a Nurse

Lina Irawan August 12, 2025 0
National Nurses Day, observed annually on May 6th, serves as a vital reminder of the profound impact...
Read More Read more about From Patient to Healer: A Survivor’s Inspiring Journey to Becoming a Nurse
Funding at a Crossroads: METAvivor Outlines High Stakes in FY 2027 Budget Battle and CDC Leadership Transition funding-at-a-crossroads-metavivor-outlines-high-stakes-in-fy-2027-budget-battle-and-cdc-leadership-transition
  • Patient Advocacy and Support

Funding at a Crossroads: METAvivor Outlines High Stakes in FY 2027 Budget Battle and CDC Leadership Transition

Nana Muazin August 11, 2025 0
WASHINGTON, D.C. — As the cherry blossoms reached their peak in the nation’s capital this April, the...
Read More Read more about Funding at a Crossroads: METAvivor Outlines High Stakes in FY 2027 Budget Battle and CDC Leadership Transition

Posts pagination

Previous 1 … 247 248 249 250 251 Next

Recent Posts

  • Beeline Medicines Secures $426 Million War Chest to Revolutionize Autoimmune Therapeutics
  • The Biological Toll of Bias: How Racial Discrimination Rewires the Human Body
  • The Architecture of the Spine: Unlocking the Mechanics of Upward-Facing Dog
  • Unveiling a New Paradigm: Genetic Changes Alone Insufficient to Explain Tumour Growth in Neurofibromatosis Type 1
  • Canada Becomes First G7 Nation to Approve Generic Semaglutide Following Rare Patent Lapse

Recent Comments

No comments to show.

Archives

  • June 2026
  • May 2026
  • September 2025
  • August 2025
  • July 2025

Categories

  • Breast Cancer Legislation and Policy
  • Breast Cancer Prevention and Lifestyle
  • Breast Cancer Surgery and Reconstruction
  • Chemotherapy and Targeted Therapy
  • Clinical Oncology Education
  • Clinical Radiology and Imaging
  • Genomics and Precision Medicine
  • Global Breast Cancer Awareness
  • Hormone Therapy and Endocrinology
  • Integrative Oncology and Holistic Care
  • Medical Research and Clinical Trials
  • Metastatic Breast Cancer Research
  • Patient Advocacy and Support
  • Psychosocial Support and Mental Health
  • Radiation Oncology
  • Survivorship and Post-Treatment
  • Treatment Innovations

You may have missed

beeline-medicines-secures-426-million-war-chest-to-revolutionize-autoimmune-therapeutics
  • Chemotherapy and Targeted Therapy

Beeline Medicines Secures $426 Million War Chest to Revolutionize Autoimmune Therapeutics

Lina Hope June 30, 2026
the-biological-toll-of-bias-how-racial-discrimination-rewires-the-human-body
  • Breast Cancer Legislation and Policy

The Biological Toll of Bias: How Racial Discrimination Rewires the Human Body

Iffa Jayyana June 30, 2026
the-architecture-of-the-spine-unlocking-the-mechanics-of-upward-facing-dog
  • Integrative Oncology and Holistic Care

The Architecture of the Spine: Unlocking the Mechanics of Upward-Facing Dog

Ali Ikhwan June 30, 2026
unveiling-a-new-paradigm-genetic-changes-alone-insufficient-to-explain-tumour-growth-in-neurofibromatosis-type-1
  • Medical Research and Clinical Trials

Unveiling a New Paradigm: Genetic Changes Alone Insufficient to Explain Tumour Growth in Neurofibromatosis Type 1

Neng Nana June 30, 2026
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Copyright © All rights reserved. | MoreNews by AF themes.